Development of sarcoidosis during adalimumab therapy for chronic plaque psoriasis

Australasian Journal of Dermatology

Volumn 52, Issue 3, 2011, Pages

  Marcella, Stefanie ^a   Welsh, Belinda ^b   Foley, Peter ^a,b,c  

^a SKIN AND CANCER FOUNDATION   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Adalimumab; Granulomatous disease; Psoriasis; Sarcoidosis; TNF antagonist; TNF inhibitor

Indexed keywords

ADALIMUMAB; ANTINUCLEAR ANTIBODY; CORTICOSTEROID; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE; EFALIZUMAB; METHOTREXATE; PREDNISOLONE; RO ANTIBODY;

ADULT; ARTHRITIS; ARTICLE; BRONCHOSCOPY; CASE REPORT; CHRONIC DISEASE; COUGHING; DISEASE EXACERBATION; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; DYSPNEA; FACE RASH; FEMALE; FOLLOW UP; HAND RASH; HUMAN; HUMAN TISSUE; LOADING DRUG DOSE; LYMPHADENOPATHY; MEDIASTINOSCOPY; PHOTOTHERAPY; PSORIASIS VULGARIS; PUNCH BIOPSY; SARCOIDOSIS; SKIN LUPUS ERYTHEMATOSUS; THORAX RADIOGRAPHY; TREATMENT DURATION; TREATMENT RESPONSE; WHEEZING;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL, HUMANIZED; FEMALE; HUMANS; PSORIASIS; SARCOIDOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80051758314     PISSN: 00048380     EISSN: 14400960     Source Type: Journal    
DOI: 10.1111/j.1440-0960.2010.00660.x     Document Type: Article

References (10)

1. Krueger G, Koo J, Lebwohl M, et al,. The impact of psoriasis on quality of life: results of a 1998 National Psoariasis Foundation patient membership survey. Arch. Dermatol. 2001; 137: 280-4. (Pubitemid 32240779)
2. Haraoui B,. Differentiating the efficacy of the tumour necrosis factor inhibitors. Semin. Arthritis Rheum. 2005; 34 (Suppl. 1): 7-11.
3. Philips MA, Lynch J, Azmi FH,. Ulcerative cutaneous sarcoidosis responding to adalimumab. J. Am. Acad. Dermatol. 2005; 53: 917. (Pubitemid 41501405)
4. Heffernan MP, Smith DI,. Adalimumab for treatment of cutaneous sarcoidosis. Arch. Dermatol. 2006; 142: 17-19. (Pubitemid 43107354)
5. Callejas-Rubio JL, Ortego-Centeno N, Lopez-Perez L,. Treatment of therapy resistant sarcoidosis with adalimumab. Clin. Rheumatol. 2005; 25: 596-7.
6. Patel SR,. Systemic sarcoidosis with bone marrow involvement responding to therapy with adalimumab; a case report. J. Med. Case Rep. 2009; 3: 8573.
7. Moller DR,. Treatment of sarcoidosis from a basic science point of view. J. Intern. Med. 2003; 253: 31-40. (Pubitemid 36120995)
8. Gonzales-Lopez MA, Blanco R, Gonzales-Vela MC, et al,. Development of sarcoidosis during etanercept therapy. Arthritis Rheum. 2006; 55: 817-20. (Pubitemid 44619198)
9. Massara A, Cavazzini L, La Corte R, et al,. Sarcoidosis appearing during anti TNF α theraphy: a new 'class effect' paradoxical phenomenon. Two case reports and literature review. Semin. Arthritis Rheum. 2010; 39: 313-19.
10. Daien CI, Monnier A, Claudepierre P, et al,. Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers; 10 cases. Rheumatology 2009; 48: 883-6.